|
Volumn 4, Issue 2, 2006, Pages 61-64
|
Melt extrusion can bring new benefits to HIV therapy: The example of Kaletra® tablets
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
LOPINAVIR PLUS RITONAVIR;
POLYMER;
PROTEINASE INHIBITOR;
VERAPAMIL;
COMPRESSION;
DISPERSION;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
DRUG MANUFACTURE;
DRUG SOLUBILITY;
FOOD INTAKE;
FREEZING;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMPLANT;
MEDICAL TECHNOLOGY;
MELT EXTRUSION;
PRIORITY JOURNAL;
REVIEW;
STENT;
SUSPENSION;
TABLET;
|
EID: 33745929028
PISSN: 11759038
EISSN: 11759038
Source Type: Journal
DOI: 10.2165/00137696-200604020-00001 Document Type: Review |
Times cited : (62)
|
References (8)
|